FDA Approves Use Of Patch For Alzheimer’s

The Food and Drug Administration has approved use of the first weekly transdermal skin patch for Alzheimer’s-related dementia.

Adlarity (donepezil) is a patch for patients with mild, moderate or severe dementia and is available in 5- or 10-mg per day forms.

The patch can be placed on the patient’s back, thigh or buttocks and will consistently deliver a well-tolerated dose of donepezil through the skin for up to seven days.

Donepezil is the most widely used medicine for patients with Alzheimer’s disease. The donepezil patch offers several advantages over the oral form of the drug. Most notably, studies show, the patch results in a lower likelihood of gastrointestinal side effects such as abdominal pain, constipation, and diarrhea.

The patch, manufactured by Corium, is expected to become available this fall.

Authors:

Florida Health Care News

About Florida Health Care News

ifoundMYdoctor.com is the online presence of Florida Health Care News, Inc., the oldest and largest family of health care information publications in the state. Since 1987, Florida Health Care News has been a highly respected, widely read and trusted source of health care information for readers throughout much of Florida.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

*